Late-Breaking Clinical Trials

Submission Deadline:
1 p.m. ET on Thursday, Dec. 7

The Late-Breaking Clinical Trial submission period is now closed. Register today for a chance to learn the latest science directly from the experts at ACC.24.

Late-Breaking Clinical Trial submissions were accepted in the following categories:

  • Major Study
  • Smaller Study/Randomized Clinical Trial
  • Multi-center Observational Study or Registry
  • Secondary Analysis of Major Clinical Trial
  • Other

Accepted Late-Breaking Clinical Trial submissions will be presented in person during one of five LBCT sessions in the Main Tent in Atlanta and streamed live on the ACC.24 virtual platform. No video/virtual presentation option will be available.

Three LBCT sessions will be co-sponsored by the Journal of the American College of Cardiology (JACC), the Journal of the American Medical Association (JAMA) and the New England Journal of Medicine (NEJM). Each accepted submission will be considered for JACC Rapid Review and publication in JACC, JAMA and NEJM. In addition, each LBCT session will be followed by a press conference with top media outlets.

ADVERTISEMENT
American College of Cardiology

© 2023 American College of Cardiology Foundation. Visit ACC.org

Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Cookie Policy Contact Us